{"id":51248,"date":"2022-11-25T14:02:34","date_gmt":"2022-11-25T13:02:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-antithrombin-market-to-reach-681-million-by-2027-at-a-4-9-cagr-researchandmarkets-com\/"},"modified":"2022-11-25T14:02:34","modified_gmt":"2022-11-25T13:02:34","slug":"global-antithrombin-market-to-reach-681-million-by-2027-at-a-4-9-cagr-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-antithrombin-market-to-reach-681-million-by-2027-at-a-4-9-cagr-researchandmarkets-com\/","title":{"rendered":"Global Antithrombin Market to Reach $681 Million by 2027 at a 4.9% CAGR – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Antithrombin: Global Strategic Business Report”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal Antithrombin Market to Reach $681 Million by 2027<\/strong>\n<\/p>\n

\nIn the changed post COVID-19 business landscape, the global market for Antithrombin estimated at US$486.2 Million in the year 2020, is projected to reach a revised size of US$681 Million by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Therapeutics, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$640.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Research segment is readjusted to a revised 3.2% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $143.3 Million, While China is Forecast to Grow at 4.7% CAGR<\/strong>\n<\/p>\n

\nThe Antithrombin market in the U.S. is estimated at US$143.3 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$120.7 Million by the year 2027 trailing a CAGR of 4.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.\n<\/p>\n

\nDiagnostics Segment to Record 4.1% CAGR<\/strong>\n<\/p>\n

\nIn the global Diagnostics segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$11.1 Million in the year 2020 will reach a projected size of US$14.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.\n<\/p>\n

\nSelect Competitors (Total 41 Featured) –<\/strong>\n<\/p>\n